Dopamine Agonists: all 968 studies that test it
Page 2 of 10. Open to participants first (53), then studies with results posted, then the rest; newest registration first within each.
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
- A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT03548584Phase 3Results posted
- Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off ReversalCompletedNCT03541356Phase 2Results posted
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive DisorderCompletedNCT03538691Phase 3Results posted
- Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use DisorderCompletedNCT03526354Phase 4Results posted
- The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-DopaCompletedNCT03521635Phase 4Results posted
- Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic InjuryCompletedNCT03496545Phase 1/2Results posted
- Brexpiprazole for Bipolar DepressionCompletedNCT03427892Phase 4Results posted
- Brexpiprazole in Borderline Personality DisorderCompletedNCT03418675Phase 2Results posted
- CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)CompletedNCT03408873Phase 4Results posted
- A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)CompletedNCT03391882Phase 3Results posted
- Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male AdultsCompletedNCT03342963Phase 1Results posted
- A Phase 3 Study With P2B001 in Subjects With Early Parkinson'sCompletedNCT03329508Phase 3Results posted
- A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" EpisodesCompletedNCT03292016Phase 2Results posted
- A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.CompletedNCT03287869Phase 3Results posted
- A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I DisorderCompletedNCT03259555Phase 3Results posted
- A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I DisorderCompletedNCT03257865Phase 3Results posted
- Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTerminatedNCT03250117Phase 1/2Results posted
- Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With SchizophreniaCompletedNCT03238326Phase 3Results posted
- Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With SchizophreniaCompletedNCT03198078Phase 3Results posted
- Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)CompletedNCT03197493Phase 2Results posted
- A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" EpisodesCompletedNCT03187301Phase 2Results posted
- Ropinirole for the Treatment of Muscle Cramps in Patients With CirrhosisCompletedNCT03176966Phase 4Results posted
- A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)CompletedNCT03149991Phase 4Results posted
- Norepinephrine-targeted Therapy for Action Control in Parkinson DiseaseCompletedNCT03115827Phase 4Results posted
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist RopiniroleCompletedNCT03038308Phase 1/2Results posted
- A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)CompletedNCT03033069Phase 2Results posted
- Dose Ranging Study of Carbidopa-levodopaCompletedNCT03023059Phase 2Results posted
- Carbidopa-levodopa in Neovascular AMDCompletedNCT03022318Phase 2Results posted
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRDCompletedNCT02977299Phase 4Results posted
- Optimizing Outcomes of Treatment-Resistant Depression in Older AdultsCompletedNCT02960763Phase 4Results posted
- A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSDTerminatedNCT02934932Phase 2Results posted
- Aripiprazole for Bipolar Disorder and Alcohol Use DisorderCompletedNCT02918370Phase 3Results posted
- Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male SubjectsCompletedNCT02875080Phase 1Results posted
- Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the DiseaseTerminatedNCT02847650Phase 2Results posted
- A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)CompletedNCT02799381Phase 3Results posted
- A Study of L-DOPA for Depression and Slowing in Older AdultsCompletedNCT02744391Phase 4Results posted
- Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02717130Not applicableResults posted
- Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor FluctuationsTerminatedNCT02687542Phase 2Results posted
- Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes SubjectsCompletedNCT02682901Phase 4Results posted
- Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm InfantsTerminatedNCT02620761Phase 2/3Results posted
- PF-06669571 In Subjects With Idiopathic Parkinson's DiseaseCompletedNCT02565628Phase 1Results posted
- Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)CompletedNCT02560389Phase 4Results posted
- Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®TerminatedNCT02549573Phase 4Results posted
- Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesCompletedNCT02544321Phase 2Results posted
- Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseCompletedNCT02542696Phase 3Results posted
- Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot StudyCompletedNCT02542410Phase 2Results posted
- Inflammation-related Alterations in Neurocircuitry: Reversal With LevodopaCompletedNCT02513485Phase 4Results posted
- Aripiprazole, Abilify Maintena Collaborative Clinical ProtocolTerminatedNCT02472652Phase 4Results posted
- Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's DiseaseCompletedNCT02469090Phase 3Results posted
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
- Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus RhythmTerminatedNCT02454283Phase 3Results posted
- A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD PatientsCompletedNCT02448914Phase 1Results posted
- A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic SchizophreniaTerminatedNCT02435836Phase 3Results posted
- Targeting Cognition in Bipolar Disorder With PramipexoleCompletedNCT02397837Phase 4Results posted
- Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational TreatmentTerminatedNCT02365870Phase 4Results posted
- Fluoxetine vs Aripiprazole Comparative Trial (FACT)TerminatedNCT02357849Phase 4Results posted
- Randomized Safety Study of CVT-301 Compared to an Observational Control GroupCompletedNCT02352363Phase 3Results posted
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue TherapyCompletedNCT02299050Phase 4Results posted
- Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesCompletedNCT02242487Phase 3Results posted
- Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF EpisodesCompletedNCT02240030Phase 3Results posted
- A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's DiseaseCompletedNCT02230904Phase 1Results posted
- A Study to Examine APL-130277 in Patients With Parkinson's DiseaseCompletedNCT02228590Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's DiseaseCompletedNCT02224664Phase 1Results posted
- A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With SchizophreniaCompletedNCT02220712Phase 1Results posted
- Study of Dexpramipexole Chronic Sinusitis With Nasal Polyps and EosinophiliaCompletedNCT02217332Phase 2Results posted
- Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious DistressCompletedNCT02196506Phase 3Results posted
- Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With ImpulsivityCompletedNCT02194933Phase 3Results posted
- Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)CompletedNCT02091882Phase 4Results posted
- Striatal Effective Connectivity to Predict Treatment Response in Cocaine MisuseCompletedNCT02080819Phase 2Results posted
- Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute SchizophreniaCompletedNCT02054702Phase 3Results posted
- Imaging Dopamine Release in DepressionCompletedNCT02033369Phase 4Results posted
- Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode SchizophreniaCompletedNCT02013622Phase 3Results posted
- Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work EnvironmentCompletedNCT02013609Phase 3Results posted
- Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety SymptomsCompletedNCT02013531Phase 3Results posted
- Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive TherapyCompletedNCT02012218Phase 3Results posted
- Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's DiseaseCompletedNCT02006121Phase 3Results posted
- Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)TerminatedNCT01987960Phase 3Results posted
- Switching From Oral Dopamine Agonists to RotigotineCompletedNCT01976871Phase 4Results posted
- A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCompletedNCT01960842Phase 3Results posted
- Aripiprazole Once-monthly in Patients With SchizophreniaCompletedNCT01959035Phase 3Results posted
- Effect of L-dopa In Subacute Back Pain PopulationCompletedNCT01951105Phase 4Results posted
- Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive DisorderTerminatedNCT01944969Phase 3Results posted
- Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant TherapyCompletedNCT01942785Phase 3Results posted
- Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive DisorderCompletedNCT01942733Phase 3Results posted
- A Short Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942161Phase 2/3Results posted
- A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With SchizophreniaCompletedNCT01942148Phase 3Results posted
- Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeCompletedNCT01922258Phase 3Results posted
- Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With SchizophreniaCompletedNCT01909466Phase 1Results posted
- Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 DiabetesCompletedNCT01883804Not applicableResults posted
- A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM DepotCompletedNCT01870999Phase 1Results posted
- A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationCompletedNCT01862640Phase 3Results posted
- PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With SchizophreniaCompletedNCT01854944Phase 1Results posted
- Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentCompletedNCT01838681Phase 3Results posted
- Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentTerminatedNCT01837797Phase 3Results posted
- Brexpiprazole in Patients With SchizophreniaCompletedNCT01810783Phase 3Results posted
- Brexpiprazole in Patients With Acute SchizophreniaCompletedNCT01810380Phase 3Results posted
- Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And ApathyCompletedNCT01782222Phase 4Results posted
- Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)CompletedNCT01770145Phase 4Results posted
- Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated PainCompletedNCT01744496Phase 4Results posted